LARS 抗体
Quick Overview for LARS 抗体 (ABIN7115841)
抗原
See all LARS 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- LARS1 antibody
-
纯化方法
- Immunogen affinity purified
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
- leucyl-tRNA synthetase
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 1:500-1:2000, IP: 1:200-1:1000, IHC: 1:20-1:200, IF: 1:20-1:200
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months
-
有效期
- 12 months
-
-
- LARS (Leucyl-tRNA Synthetase (LARS))
-
别名
- LARS1
-
背景
-
Synonyms: Leucine--tRNA ligase, cytoplasmic|Leucyl-tRNA synthetase (LeuRS, cLRS)|LARS1|KIAA1352|LARS
Background: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid(AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs.
-
分子量
- 135-140 kDa
-
基因ID
- 51520
-
UniProt
- Q9P2J5
-
途径
- EGFR Signaling Pathway
抗原
-